Danaher Corporation $DHR Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. decreased its position in Danaher Corporation (NYSE:DHR) by 1.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,238 shares of the conglomerate’s stock after selling 660 shares during the quarter. Securian Asset Management Inc.’s holdings in Danaher were worth $6,566,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in DHR. GHP Investment Advisors Inc. raised its holdings in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares in the last quarter. Sierra Ocean LLC increased its stake in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares during the last quarter. Red Tortoise LLC increased its stake in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in Danaher in the first quarter valued at approximately $31,000. Finally, Ramirez Asset Management Inc. purchased a new position in Danaher in the second quarter valued at approximately $40,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 11.20% of the company’s stock.

Danaher Stock Performance

NYSE:DHR opened at $208.06 on Tuesday. The firm’s fifty day moving average price is $201.76 and its 200 day moving average price is $197.42. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $274.21. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm has a market cap of $148.98 billion, a price-to-earnings ratio of 44.27, a price-to-earnings-growth ratio of 2.98 and a beta of 0.77.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period last year, the firm posted $1.72 EPS. Danaher’s quarterly revenue was up 3.4% on a year-over-year basis. On average, sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 27.23%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on DHR shares. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a research report on Tuesday, September 2nd. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price on the stock in a research report on Friday, July 11th. Evercore ISI raised their target price on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Finally, Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Seventeen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $245.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.